Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can)

Abstract
The metabolic syndrome includes presence of several metabolic risk factors, such as obesity, hypertension, insulin resistance/hyperglycaemia and dyslipidaemia.1 These factors have, separately and jointly, been associated with an increased risk of cardiovascular diseases.2–4 To date, little is known about the metabolic syndrome and cancer risk.5 Recent prospective studies have either focused on the association between the metabolic syndrome and risk of specific cancers, mainly colorectal and prostate cancer, or between a single factor in the metabolic syndrome and cancer risk.5 It remains to be elucidated if factors within the metabolic syndrome act in synergy on the risk of cancer.